Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

47.12 +0.47 (+1.01%)
Streaming Delayed Price Updated: 2:59 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,926,411
Open 46.52
Bid (Size) 47.11 (900)
Ask (Size) 47.12 (900)
Prev. Close 46.65
Today's Range 46.52 - 47.73
52wk Range 42.52 - 63.33
Shares Outstanding 2,222,113,553
Dividend Yield 5.26%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 Cash-Producing Stock to Keep an Eye On and 2 We Find Risky
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
These 2 Dividend ETFs Are a Retiree's Best Friend ↗
Exchange-traded funds provide investors with exposure to a basket of stocks. Some also pay dividends. 
Via The Motley Fool
Topics Artificial Intelligence Bonds ETFs

Performance

YTD
-17.0%
-17.0%
1 Month
+8.0%
+8.0%
3 Month
-2.2%
-2.2%
6 Month
-0.2%
-0.2%
1 Year
-17.0%
-17.0%

More News

Read More
News headline image
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Stay informed with the top movers within the S&P500 index on Friday. ↗
Via Chartmill
News headline image
Discover which S&P500 stocks are making waves on Friday. ↗
Via Chartmill
News headline image
Tech Rebounds After Selloff, Bitcoin Craters To $97,000: What's Moving Markets Friday? ↗
Via Benzinga
News headline image
Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy ↗
Via Benzinga
News headline image
Friday's session: gap up and gap down stock in the S&P500 index ↗
Via Chartmill
News headline image
Bristol Myers Slumps After Its Heart Condition Study Gets The Boot ↗
Via Investor's Business Daily
News headline image
Discover the top S&P500 movers in Friday's pre-market session. ↗
Via Chartmill
News headline image
BMY Stock Slumps 5% After It Scraps Heart Drug Study ↗
Via Stocktwits
News headline image
Update on Phase 3 Librexia ACS Trial
From Bristol Myers Squibb
Via Business Wire
News headline image
3 Reasons to Avoid BMY and 1 Stock to Buy Instead
Via StockStory
Topics Stocks
News headline image
Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run ↗
Via Benzinga
News headline image
3 Healthcare Stocks Topping a 2025 List of Dividend Yields ↗
Via The Motley Fool
News headline image
Jim Cramer Is Backing Off Bristol-Myers, But These 2 Chinese Stocks Are Good ↗
Via Benzinga
News headline image
Eledon Pharmaceuticals (ELDN) Plummets Nearly 50% Amidst Mixed Phase 2 Trial Results, Sparking Investor Concern
Via MarketMinute
News headline image
Cliff Asness: The Stock Market is Expensive, Not a Bubble – A Call for Rationality in a Less Efficient Market
Via MarketMinute
Topics Economy
News headline image
Bristol Myers Squibb Prices €5 Billion of Senior Unsecured Notes
From Bristol Myers Squibb
Via Business Wire
News headline image
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership ↗
Via Benzinga
News headline image
Cleveland-Cliffs, Meta And Rocket On CNBC's 'Final Trades' ↗
Via Benzinga
News headline image
Bristol Myers Squibb Co (NYSE:BMY) Presents a Compelling Value Investment Case ↗
Via Chartmill
Topics Intellectual Property
News headline image
Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2025
From Bristol Myers Squibb
Via Business Wire

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 47.12
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 11/17/25 02:59 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 104.71B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 105B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.